BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma J, Cai X, Kang L, Chen S, Liu H. Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis. J Cancer 2021;12:1307-17. [PMID: 33531976 DOI: 10.7150/jca.49702] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo Y, He Z, Liu W, Zhou F, Liu T, Wang G, Bravo L. DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/3369858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu L, Du X, Fang J, Zhao J, Guo Y, Zhao Y, Zou C, Yan X, Li W. Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma. J Inflamm Res 2021;14:4969-85. [PMID: 34611422 DOI: 10.2147/JIR.S334041] [Reference Citation Analysis]
3 Fan S, Wang Z, Zhao L, Zhao C, Yuan D, Wang J. A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer. Front Genet 2021;12:676845. [PMID: 34267780 DOI: 10.3389/fgene.2021.676845] [Reference Citation Analysis]